[pp.int.general] ( pharmaceutical ) patents

coretx at piratenpartij.nl coretx at piratenpartij.nl
Tue May 26 22:47:12 CEST 2009

I suggest that all that are working on ( pharmaceutical ) patent issues
take a look @ the following document.


CEPR - Center for Economical and Policy research.
Financing Drug Research: What are the issues ? - By Dean Baker.

Here is his list of used references:

Baker, D. and N. Chatani, 2002. "Promoting Good Ideas on Drugs: Are Patents
the Best 
Way? " Center for Economic and Policy Research, 
Dimasi, J. and H Grabowski, 2004. "Patents and R&D Frameworks: Comments on
Hubbard and Love Trade Framework for Financing Pharmaceutical R&D." Tufts
for the Study of Drug Development, Tufts University 
Dimasi J. R. Hansen, and H. Grabowski, 2003. "The Price of Innovation: New
of Drug Development Costs." Journal of Health Economics, 22 151-185. 
Ernst & Young LLP. 2001. Pharmaceutical Industry R&D Costs: Key Findings
about the 
Public Citizen Report. Pharmaceutical Research and Manufacturers of
Hay, J. and D. Zammit 2002. “Vaccine Policy Perspectives: Market
University of Southern California, paper prepared for the Institute of
Committee on Evaluation of Vaccine Purchase Finance in the United States.  
Hollis, A. 2004. "An Efficient Reward System for Pharmaceutical
Unpublished Manuscript, Department of Economics, University of Calgary.  
Hubbard, T. and J. Love, 2004. "A New Trade Framework for Global Healthcare
Plos Biology, V2, #2. [http://www.plosbiology.org/plosonline/?request=get- 
Kremer, M. 2000. "Creating Markets For New Vaccines, Part I: Rationale,"
Bureau of Economic Research Working Paper # 7716. 
Kremer, M. 1998. "Patent Buyouts: A Mechanism for Encouraging Innovation:
Journal of Economics. 113, 1137-1167. 
Kucinich, D. 2004. "The Free Market Drug Act of 2004."  
Love, J. 2003. "From TRIPS to RIPS: A Better Trade Framework to Support
in Medical Technologies."

More information about the pp.international.general mailing list